Noisy-le-Sec, France

Gaston Amiard

This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaston Amiard. Retrieved from https://idiyas.com/inventor/gaston-amiard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaston Amiard: Innovator in Antibiotic Development

Introduction

Gaston Amiard is a notable inventor based in Noisy-le-Sec, France. He has made significant contributions to the field of antibiotic research, particularly through his innovative patent.

Latest Patents

Amiard holds a patent for a novel stable crystalline hydrate of the D form of the syn isomer of sodium 3-acetoxymethyl-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-ceph-3-eme-4-carboxylate. This compound exhibits excellent antibiotic activity against both gram-negative and gram-positive bacteria. The patent outlines a process for its preparation, showcasing Amiard's expertise in pharmaceutical chemistry.

Career Highlights

Amiard is associated with Roussel Uclaf, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in antibiotic treatments, reflecting his commitment to improving healthcare outcomes.

Collaborations

Throughout his career, Amiard has collaborated with notable colleagues, including Walter Duerckheimer and Dieter Bormann. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Gaston Amiard's contributions to antibiotic development through his innovative patent highlight his role as a significant figure in the pharmaceutical industry. His work continues to influence the field and improve treatment options for bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…